Vimarsana
Biggest News Aggregation in the World

Puretech Scientific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Puretech Scientific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Puretech Scientific Today - Breaking & Trending Today

WVWC's Moore selected for 'Young Guns' class of 2024 | News, Sports, Jobs - Vimarsana News

WVWC's Moore selected for 'Young Guns' class of 2024 | News, Sports, Jobs

BUCKHANNON — West Virginia Wesleyan College President James Moore is smiling from the cover of the new issue of “West Virginia Executive” after being name

Of Note: Ryman Hospitality sees Q2 revenue increase - Vimarsana News

Of Note: Ryman Hospitality sees Q2 revenue increase

Also: McNeilus to expand operations in Murfreesboro; Iron Path finalizes investment related to acquisition

Business News: July 2023 - Chemical Engineering - Vimarsana News

Business News: July 2023 - Chemical Engineering

(Page 1) ALPLA to construct PET recycling plant in South Africa; Solvay to produce green hydrogen for its peroxides operations in Italy; BASF to expand production capacity for bio-based alkyl polyglucosides; Sumitomo acquires sulfuric acid company in the U.S.

The Chemours Company to sell glycolic acid business for $137 million - Vimarsana News

The Chemours Company to sell glycolic acid business for $137 million

The Chemours Company has entered into a definitive agreement to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capi ...

Chemours sells chemical business for $137 million - Delaware Business Now - Vimarsana News

Chemours sells chemical business for $137 million - Delaware Business Now

The Chemours Company reached a definitive agreement to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capital, a private equity firm focused on middle market investments across the specialty industrial and healthcare s